Secretases as targets for the treatment of Alzheimer’s disease
- 1 October 2000
- journal article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (10) , 392-397
- https://doi.org/10.1016/s1357-4310(00)01759-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'Nature Medicine, 2000
- Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2000
- A Role for Presenilin-1 in Nuclear Accumulation of Ire1 Fragments and Induction of the Mammalian Unfolded Protein ResponseCell, 1999
- The Presenilins in Alzheimer's Disease--Proteolysis Holds the KeyScience, 1999
- Laying it on thickNature, 1999
- Tau Mutations Cause Frontotemporal DementiasNeuron, 1998
- The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's diseaseTrends in Cell Biology, 1998
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996
- Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseTrends in Pharmacological Sciences, 1991